Hypoxic-Ischemic Neonatal Encephalopathy: Animal Experiments for Neuroprotective Therapies

Hypoxic-ischemic neonatal encephalopathy and ensuing brain damage is still an important problem in modern perinatal medicine. In this paper, we would like to share some of the results of our recent studies on neuroprotective therapies in animal experiments, as well as some literature reviews. From t...

Full description

Bibliographic Details
Main Authors: Hiroshi Sameshima, Tsuyomu Ikenoue
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:Stroke Research and Treatment
Online Access:http://dx.doi.org/10.1155/2013/659374
id doaj-21e39ec8ab7e45beb31b20bbe79e57b7
record_format Article
spelling doaj-21e39ec8ab7e45beb31b20bbe79e57b72021-07-02T01:21:55ZengHindawi LimitedStroke Research and Treatment2090-81052042-00562013-01-01201310.1155/2013/659374659374Hypoxic-Ischemic Neonatal Encephalopathy: Animal Experiments for Neuroprotective TherapiesHiroshi Sameshima0Tsuyomu Ikenoue1Department of Obstetrics and Gynecology and Center for Perinatal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kiyotake, Kihara, Miyazaki 889-1692, JapanDepartment of Obstetrics and Gynecology and Center for Perinatal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kiyotake, Kihara, Miyazaki 889-1692, JapanHypoxic-ischemic neonatal encephalopathy and ensuing brain damage is still an important problem in modern perinatal medicine. In this paper, we would like to share some of the results of our recent studies on neuroprotective therapies in animal experiments, as well as some literature reviews. From the basic animal studies, we have now obtained some possible candidates for therapeutic measures against hypoxic-ischemic neonatal encephalopathy. For example, they are hypothermia, rehabilitation, free radical scavenger, neurotrophic factors and growth factors, steroid, calcium channel blocker, vagal stimulation, some anti apoptotic agents, pre- and post conditioning, antioxidants, cell therapy with stem cells, modulators of K(+)-ATP channels, and so on. Whether combination of these therapies may be more beneficial than any single therapy needs to be clarified. Hypoxia-ischemia is a complicated condition, in which the cause, severity, and time-course are different in each case. Likewise, each fetus has its own inherent potentials such as adaptation, preconditioning-tolerance, and intolerance. Therefore, further extensive studies are required to establish an individualized strategy for neuroprotection against perinatal hypoxic-ischemic insult.http://dx.doi.org/10.1155/2013/659374
collection DOAJ
language English
format Article
sources DOAJ
author Hiroshi Sameshima
Tsuyomu Ikenoue
spellingShingle Hiroshi Sameshima
Tsuyomu Ikenoue
Hypoxic-Ischemic Neonatal Encephalopathy: Animal Experiments for Neuroprotective Therapies
Stroke Research and Treatment
author_facet Hiroshi Sameshima
Tsuyomu Ikenoue
author_sort Hiroshi Sameshima
title Hypoxic-Ischemic Neonatal Encephalopathy: Animal Experiments for Neuroprotective Therapies
title_short Hypoxic-Ischemic Neonatal Encephalopathy: Animal Experiments for Neuroprotective Therapies
title_full Hypoxic-Ischemic Neonatal Encephalopathy: Animal Experiments for Neuroprotective Therapies
title_fullStr Hypoxic-Ischemic Neonatal Encephalopathy: Animal Experiments for Neuroprotective Therapies
title_full_unstemmed Hypoxic-Ischemic Neonatal Encephalopathy: Animal Experiments for Neuroprotective Therapies
title_sort hypoxic-ischemic neonatal encephalopathy: animal experiments for neuroprotective therapies
publisher Hindawi Limited
series Stroke Research and Treatment
issn 2090-8105
2042-0056
publishDate 2013-01-01
description Hypoxic-ischemic neonatal encephalopathy and ensuing brain damage is still an important problem in modern perinatal medicine. In this paper, we would like to share some of the results of our recent studies on neuroprotective therapies in animal experiments, as well as some literature reviews. From the basic animal studies, we have now obtained some possible candidates for therapeutic measures against hypoxic-ischemic neonatal encephalopathy. For example, they are hypothermia, rehabilitation, free radical scavenger, neurotrophic factors and growth factors, steroid, calcium channel blocker, vagal stimulation, some anti apoptotic agents, pre- and post conditioning, antioxidants, cell therapy with stem cells, modulators of K(+)-ATP channels, and so on. Whether combination of these therapies may be more beneficial than any single therapy needs to be clarified. Hypoxia-ischemia is a complicated condition, in which the cause, severity, and time-course are different in each case. Likewise, each fetus has its own inherent potentials such as adaptation, preconditioning-tolerance, and intolerance. Therefore, further extensive studies are required to establish an individualized strategy for neuroprotection against perinatal hypoxic-ischemic insult.
url http://dx.doi.org/10.1155/2013/659374
work_keys_str_mv AT hiroshisameshima hypoxicischemicneonatalencephalopathyanimalexperimentsforneuroprotectivetherapies
AT tsuyomuikenoue hypoxicischemicneonatalencephalopathyanimalexperimentsforneuroprotectivetherapies
_version_ 1721345059952001024